GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the prescription question that gets asked weekly, answered properly — 21 comments in the full submission. View in context.
967
c/glp1eu·submitted 2 years ago by u/spain_receta

the prescription question that gets asked weekly, answered properly

Questionbranch of 6 comments

The title is the argument: the prescription question that gets asked weekly, answered properly. Here is the rest of it. Kept the prescription and the receipt for a claim, purely because a thread here told me to. Both were requested. A supply notice in one member state made the front page here and had no effect at all…

Read the full submission and all 21 comments →

This branch

6 comments, started 2 years ago
u/sten_bhattacharya77 points·2 years ago

the same product has different names and pack sizes across the union

replysharereportpermalink
u/marit_mwangi32 points·2 years ago

Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.

replysharereportpermalink
u/camila_marchand47 points·2 years ago

Are you comparing the same presentation, or different pack sizes?

replysharereportpermalink
u/no_refunds_nr60 points·2 years ago

say which country or the thread is useless

replysharereportpermalink
u/ilias_steiner0 points·2 years ago

say which country or the thread is useless

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

replysharereportpermalink
u/vikram_asante32 points·2 years ago

Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.